1) Macrovascular complications
大血管并发症
1.
Study on the relationship between DNA oxidative damage and macrovascular complications in patients with type 2 diabetes
2型糖尿病患者大血管并发症与DNA氧化损伤的关系研究
2.
Objective: Detecting Monocyte chemoattractant protein-1 (MCP-1) in serum from patients with type 2 diabetes and type 2 diabetic patients with macrovascular complications.
目的：通过测定2型糖尿病及其合并大血管并发症患者血清中MCP-1的水平及马来酸罗格列酮(文迪雅)对MCP-1的干预，探讨MCP-1在胰岛素抵抗、2型糖尿病及其大血管并发症发生发展中的作用。
3.
This review analyzes several large randomized prospective clinical trials,and elaborates on the effects of tight glycaemic control on diabetic macrovascular complications.
强化降糖治疗可降低糖尿病微血管并发症,但对大血管并发症的作用却一直没有定论。
2) vascular complication
血管并发症
1.
Relationship between serum uric acid and insulin resistance and vascular complications of type 2 diabetes;
血尿酸与2型糖尿病胰岛素抵抗及血管并发症的关系
2.
Results: Serum TG,TC,LDL-C,ApoB level elevated in diabetic patients and high TG,TC,LDL-C,ApoB level may be an important risk factor for type 2 diabetic vascular complications.
结果:提示2型糖尿病患者血清血脂中TG、TC、LDL-C、ApoB水平升高是血管并发症的危险因素,而HDL-C、ApoA1(抗动脉粥样硬化的指标)则明显下降。
3.
Objective To explore the occurrence of vascular complications after applying BoomerangTM(vascular closure device) to block femoral artery.
目的探讨心脏介入治疗患者应用BoomerangTM血管封堵器封堵股动脉后血管并发症的发生情况。
3) vascular complications
血管并发症
1.
The relationship between excretion rate of urinary album and vascular complications of diabetes;
尿微量白蛋白排泄率与糖尿病血管并发症的关系
2.
Objective To investigate the change of plasma von Willebrand factor cleaving protease(vWF-cp) activity level in patients with type 2 diabetes mellitus(T2DM) and to study its clinical significance in diabetes mellitus vascular complications.
目的检测2型糖尿病患者血浆血管性血友病因子裂解酶(vWF-cp)活性,探讨其在糖尿病血管并发症中的意义。
3.
Methods A clinical analyses of 30 type 2 diabetic patients with vascular complications (group A) was conducted in comparison with type 2 diabetic patients without vascular complications (group B) and patients with impaired glucose tolerance (IGT, group C).
方法选择2型糖尿病合并肾病患者30例(A组),并与2型糖尿病无血管并发症者(B组)、糖耐量受损(IGT)者(C组)作比较;同时选择有2型糖尿病家族史健康人(D组)和无2型糖尿病家族史健康人(E组)各30例作为对照,分别检测UM、ET并进行统计分析。
4) blood vessel complication
血管并发症
1.
the relationship between visceral obesity and blood vessel complication in subjects with type 2 diabetes;
2型糖尿病病人的内脏脂肪性肥胖与血管并发症的关系
2.
Objective To investigate the effects of removing artery sheath catheter at different time points on blood vessel complications after PCI operation.
目的探讨两种不同时间拔除动脉鞘管护理方法对PCI术后血管并发症的影响。
5) Macrovascular Diseases
糖尿病大血管并发症
1.
The Research of the Association of the Level of Serum BH4 and Macrovascular Diseases induced by diabetes mellitus;
血浆BH4水平与2型糖尿病大血管并发症的相关性研究
6) Microvascular complications
微血管并发症
1.
Objective:To assess the prevalence of obesity,hypertension, diabetic microvascular complications and the risk factors associated with diabetic microvascular complications of T2DM patients from the diabetic complication assessment database of PLA 306 hospital from 1994.
目的研究1994年1月～2006年12月在解放军306医院参加糖尿病并发症筛查的2型糖尿病患者的肥胖症患病率、高血压患病率、糖尿病微血管并发症患病率及糖尿病微血管并发症的临床相关因素,并与同期全国的调查结果相比较,为糖尿病微血管并发症临床治疗与预防提供参考依据。
补充资料：并发症
并发症
complication
又称“合并症”，指在一种疾病的发展过程中引起的另一种疾病或症状，常把后者称为前者的并发症。早期而积极的治疗可以减少并发症的发生。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条